78 results
Page 3 of 4
424B3
hwk53szatg nxv9pcq5r
2 Jun 21
Prospectus supplement
10:09am
424B3
8h8yin7897or
2 Jun 21
Prospectus supplement
10:08am
6-K
EX-99.1
v8qyoplfd
5 May 21
Agreement and Plan of Merger
5:19pm
6-K
EX-99.1
4qwjz
5 May 21
Amryt Reports Record Q1 2021 Financial and Operating Results
9:40am
20-F
EX-2.7
bu9jzb
30 Apr 21
Annual report (foreign)
12:53pm
20-F
8688qnhflamg u46s8e1
30 Apr 21
Annual report (foreign)
12:53pm
424B3
9u1bmg0
4 Mar 21
Prospectus supplement
8:38am
6-K
EX-99.1
h6oxi6
4 Mar 21
Amryt Announces Record FY 2020 Results
8:20am
424B4
gf95l27vfpx4y1sn fa
14 Jan 21
Prospectus supplement with pricing info
9:30am
F-1/A
anr5m
12 Jan 21
Registration statement (foreign) (amended)
12:00am
F-1
05c8h227es
8 Jan 21
Registration statement (foreign)
4:58pm
DRS
bxph8w
18 Dec 20
Draft registration statement
12:00am
6-K
EX-10.1
eq38pxwca2
9 Dec 20
Current report (foreign)
4:23pm
6-K
EX-10.2
1mfyemv3 e42mom3dasm
9 Dec 20
Current report (foreign)
4:23pm
6-K
EX-99.1
nwvin9s51 fl
5 Nov 20
Amryt Reports Record Q3 2020 Results - Raising FY 2020 Revenue Guidance
7:55am
6-K
EX-99.1
xncybf0zv jn
3 Nov 20
Current report (foreign)
8:45am
6-K
EX-99.1
t6le9s3w
29 Oct 20
Amryt Announces Positive Results from Phase 3 Trial of Filsuvez® In Epidermolysis Bullosa
8:00am
6-K
EX-99.1
dpwl45sgury70bxixs
6 Aug 20
Amryt Announces Q2 2020 Results and Issues Positive Revenue Guidance for Fy 2020
9:43am
424B4
e69x4qp1jq3o889
8 Jul 20
Prospectus supplement with pricing info
4:05pm
F-1/A
gq5ypvkm
6 Jul 20
Registration statement (foreign) (amended)
5:28pm